You are viewing: Rest Of Europe Biopreservation Market analysis
Part of: Biopreservation Market (Global)

The Rest Of Europe Biopreservation Market was valued at $71.2 Million in 2024 and projected to reach to $97.6 Million by 2029, representing a compound annual growth rate of 6.5%. Rest Of Europe's biopreservation market is positioned for steady growth as healthcare institutions increasingly recognize the value of advanced preservation technologies for cell therapy, tissue engineering, and regenerative medicine applications.

Rest Of Europe Biopreservation Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Biopreservation Market Trends and Insights

  • Rest Of Europe is experiencing steady adoption of biopreservation technologies driven by increasing demand for cell and tissue banking, regenerative medicine applications, and clinical research infrastructure development.
  • The region's growth trajectory reflects rising investments in life sciences infrastructure and regulatory support for advanced preservation methodologies. Rest Of Europe's biopreservation sector is characterized by growing pharmaceutical and biotechnology sector expansion, coupled with heightened awareness of personalized medicine and biobanking initiatives.
  • Between 2024 and 2029, Rest Of Europe is expected to see accelerated adoption of cryopreservation and controlled-rate freezing technologies across academic institutions, contract research organizations, and emerging biotech companies.
  • The market dynamics in Rest Of Europe are shaped by healthcare modernization efforts, increased R&D spending, and collaborative partnerships within the European research ecosystem..

Key Market Statistics

  • CAGR (2024-2029) 6.5% CAGR
  • Market Size, 2024 ~USD 71.2 Million
  • Forecast, 2029 ~USD 97.6 Million
  • Country Rest Of Europe

Rest Of Europe Biopreservation Market Overview

Market Valuation Growth :

Rest Of Europe biopreservation market valued at USD 71.2 million in 2024, projected to reach USD 97.6 million by 2029, demonstrating consistent market expansion and investment opportunities.

Steady Regional CAGR :

The region exhibits a 6.5% CAGR through 2029, reflecting moderate but sustainable growth driven by increasing healthcare infrastructure investments and regulatory support for biobanking initiatives.

Cell and Tissue Banking Demand :

Rising adoption of biopreservation technologies in Rest Of Europe is fueled by growing demand for advanced cell and tissue banking solutions supporting regenerative medicine and personalized healthcare applications.

Clinical Research Infrastructure :

Expansion of clinical research capabilities across Rest Of Europe countries is driving biopreservation technology adoption, with increased focus on sample preservation for long-term research studies and therapeutic development.

Rest Of Europe Biopreservation Market Dynamics

  • The region's growing investment in clinical research infrastructure and biobanking facilities is creating sustained demand for cryopreservation and biopreservation solutions.
  • Regulatory harmonization efforts and cross-border collaboration initiatives are expected to facilitate market expansion and technology adoption across Rest Of Europe countries.
  • The 6.5% CAGR reflects a maturing market with strong fundamentals and increasing clinical applications driving long-term growth prospects..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Rest Of Europe biopreservation market is valued at USD 71.2 million in 2024 with projected growth to USD 97.6 million by 2029.
    • Rest Of Europe demonstrates a steady 6.5% CAGR, reflecting moderate but consistent market expansion driven by regenerative medicine and biobanking demand.
    • Rest Of Europe's growth is supported by increasing pharmaceutical R&D investments and regulatory frameworks promoting advanced preservation technologies.
    • Rest Of Europe is witnessing rising adoption of cryopreservation solutions across academic, clinical, and commercial research institutions.

    Biopreservation Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment BIOPRESERVATION EQUIPMENT (Product)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.8% from 2024 to 2029
    Largest Segment BIOPRESERVATION MEDIA (Product)
    Market Size Base Year (Billions) ~USD 4.45 (2024)
    Revenue Forecast (Billions) ~USD 7.1 (2029)
    Segments Covered Product, Type, Biospecimen, Application, End User, Transplant Type

    Rest Of Europe Biopreservation Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Biopreservation Accessories
    • Biopreservation Equipment
    • Biopreservation Media

    By Type

    • Alarm Monitoring Systems
    • Centrifuges
    • Cryogenic Storage Systems
    • Cryopreservation Media
    • Freezers
    • Hypothermic Preservation Media
    • Incubators
    • Other Biopreservation Equipment
    • Other Equipment
    • Refrigerators
    • Temperature Control Systems
    • Thawing Equipment

    By Biospecimen

    • Human Tissue Samples
    • Organs
    • Other Biospecimens
    • Stem Cells

    By Application

    • Other Applications
    • Research Applications
    • Therapeutic Applications

    By End User

    • Biobanks
    • Gene Banks
    • Hospitals
    • Other End Users

    By Transplant Type

    • Cord Blood Transplants
    • Organ Transplants

    Target Audience

    • Biopreservation Technology Manufacturers : Need Rest Of Europe market data to identify growth opportunities, assess regional demand for cryopreservation systems, and develop localized product strategies for European healthcare providers.
    • Healthcare and Research Institutions : Require market insights to justify biopreservation infrastructure investments, benchmark against regional adoption rates, and plan facility upgrades aligned with Rest Of Europe growth trends.
    • Investment and Private Equity Firms : Seek detailed market analysis to evaluate biopreservation sector opportunities in Rest Of Europe, assess portfolio company growth potential, and identify acquisition targets in the region.
    • Regulatory and Policy Bodies : Need comprehensive market data to develop biobanking regulations, assess clinical research infrastructure needs, and create supportive policies for biopreservation technology adoption across Rest Of Europe.
    • Consulting and Strategy Firms : Require Rest Of Europe-specific market intelligence to advise clients on market entry strategies, competitive positioning, and growth opportunities in the regional biopreservation sector.

    Reasons to Buy this Report

    • Regional Market Sizing : Obtain precise market valuation data specific to Rest Of Europe, enabling accurate budget allocation and investment decisions for biopreservation technology expansion in the region.
    • Growth Trajectory Analysis : Understand the 6.5% CAGR trajectory and USD 26.4 million growth opportunity through 2029, allowing strategic planning for market entry and competitive positioning in Rest Of Europe.
    • Segment-Specific Insights : Access detailed analysis of cell and tissue banking demand, regenerative medicine applications, and clinical research infrastructure drivers unique to Rest Of Europe markets.
    • Competitive Landscape Intelligence : Benchmark your biopreservation solutions against regional market dynamics and identify growth opportunities specific to Rest Of Europe healthcare institutions and research facilities.
    • Strategic Investment Guidance : Make informed decisions on market expansion, partnership development, and resource allocation based on comprehensive Rest Of Europe biopreservation market forecasts and trend analysis.

    Frequently asked questions

    What is the current market size of biopreservation in Rest Of Europe?

    Rest Of Europe's biopreservation market was valued at USD 71.2 million in 2024 and is expected to grow to USD 97.6 million by 2029.

    What is the projected growth rate for Rest Of Europe biopreservation market?

    Rest Of Europe biopreservation market is projected to grow at a CAGR of 6.5% from 2024 to 2029.

    What are the primary drivers of biopreservation market growth in Rest Of Europe?

    Rest Of Europe's market growth is driven by increasing demand for cell and tissue banking, regenerative medicine applications, rising pharmaceutical R&D investments, and expanding biobanking infrastructure.

    Which technologies are gaining traction in Rest Of Europe biopreservation market?

    Rest Of Europe is experiencing increased adoption of cryopreservation and controlled-rate freezing technologies across research institutions and clinical facilities.

    What sectors are contributing to biopreservation demand in Rest Of Europe?

    Rest Of Europe's biopreservation demand is driven by pharmaceutical companies, biotechnology firms, academic research institutions, contract research organizations, and clinical laboratories.

    RESEARCH METHODOLOGY

    The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Biopreservation market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

    The four steps involved in estimating the market size are:

    Collecting Secondary Data

    The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Biopreservation market. A database of the key industry leaders was also prepared using secondary research.

    Collecting Primary Data

    The primary research data was conducted after acquiring knowledge about the Biopreservation market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as biobanks, gene banks, hospitals, and academic research institute) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, Latin America, and GCC. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

    A breakdown of the primary respondents is provided below:

    Breakdown of Primary Participants:

    Biopreservation Market Size, and Share

    Note 1: *Others include sales managers, marketing managers, and product managers.

    Note 2: Tiers are defined based on a company’s total revenue as of 2023: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    All major product manufacturers offering various Biopreservation were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Biopreservation market was also split into various segments and subsegments at the region and country level based on:

    • Product mapping of various manufacturers for each type of Biopreservation market at the regional and country-level 
    • Relative adoption pattern of each Biopreservation market among key application segments at the regional and/or country-level 
    • Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country level. 
    • Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level 

    Global Biopreservation Market Size: Top Down Approach

    Biopreservation Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Global Biopreservation Market Size: Bottom-Up Approach

    Biopreservation Market Size, and Share

    Data Triangulation

    After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Biopreservation industry.

    Market Definition

    Biopreservation is a technique used for the storage of cells and tissues in a hypothermic or chemical environment to preserve biological samples with sustained integrity. The different types of biospecimen stored include human tissue samples, stem cells, and organs, which are majorly used in therapeutic and research applications. These high-yielding cell lines need to be preserved in order to provide optimum yield, viability, and productivity, which can be achieved by cryopreservation and vitrification in a hypothermic storage environment. Biopreservation is a rapidly emerging field of specimen procurement, processing, preservation and banking which requires a close collaboration between clinicians, engineers and scientists coming from academia, small private enterprises or huge industrial companies.

    Key Stakeholders

    • Senior Management
    • Finance/Procurement Department
    • Doctors/HCPs
    • Researchers
    • Lab Managers/Technicians
    • End Users/Operators

    Report Objectives

    • To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To define, describe, segment, and forecast the Biopreservation market by product, biospecimen, application, end user, and region.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall Biopreservation market
    • To forecast the size of the Biopreservation market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, Middle East & Africa, and GCC.
    • To profile key players in the Biopreservation market and comprehensively analyze their core competencies and market shares
    • To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Biopreservation market.
    • To benchmark players within the Biopreservation market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

    Available Customizations

    MarketsandMarkets offers the following customizations for this market report:

    • Additional country-level analysis of the Biopreservation market
    • Profiling of additional market players (up to 5)

    Product Analysis

    • Product matrix, which provides a detailed comparison of the product portfolio of each company in the Biopreservation Market

    Get the Full Biopreservation Market Report

    Full forecast, segment splits, and company analysis for all Biopreservation Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status